nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP3A4—Temozolomide—malignant glioma	0.481	1	CbGbCtD
Sitagliptin—Parosmia—Temozolomide—malignant glioma	0.0127	0.0304	CcSEcCtD
Sitagliptin—Lung disorder—Temozolomide—malignant glioma	0.0116	0.0279	CcSEcCtD
Sitagliptin—Herpes zoster—Temozolomide—malignant glioma	0.0109	0.0262	CcSEcCtD
Sitagliptin—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—COX8A—malignant glioma	0.01	0.0998	CbGpPWpGaD
Sitagliptin—CYP2C8—Diclofenac Metabolic Pathway—CYP2B6—malignant glioma	0.00952	0.0946	CbGpPWpGaD
Sitagliptin—Neck pain—Carmustine—malignant glioma	0.00863	0.0207	CcSEcCtD
Sitagliptin—Musculoskeletal pain—Temozolomide—malignant glioma	0.00834	0.02	CcSEcCtD
Sitagliptin—CYP2C8—Diclofenac Metabolic Pathway—CYP2C18—malignant glioma	0.00826	0.082	CbGpPWpGaD
Sitagliptin—Gastroenteritis—Temozolomide—malignant glioma	0.00675	0.0161	CcSEcCtD
Sitagliptin—Face oedema—Carmustine—malignant glioma	0.00598	0.0143	CcSEcCtD
Sitagliptin—Face oedema—Temozolomide—malignant glioma	0.00578	0.0138	CcSEcCtD
Sitagliptin—Breast disorder—Temozolomide—malignant glioma	0.00541	0.0129	CcSEcCtD
Sitagliptin—Bronchitis—Temozolomide—malignant glioma	0.00497	0.0119	CcSEcCtD
Sitagliptin—Hyperglycaemia—Carmustine—malignant glioma	0.00483	0.0115	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00481	0.0115	CcSEcCtD
Sitagliptin—Pneumonia—Carmustine—malignant glioma	0.0048	0.0115	CcSEcCtD
Sitagliptin—Erectile dysfunction—Temozolomide—malignant glioma	0.00476	0.0114	CcSEcCtD
Sitagliptin—Depression—Carmustine—malignant glioma	0.00476	0.0114	CcSEcCtD
Sitagliptin—Weight increased—Temozolomide—malignant glioma	0.00471	0.0113	CcSEcCtD
Sitagliptin—Renal failure—Carmustine—malignant glioma	0.00469	0.0112	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Carmustine—malignant glioma	0.00468	0.0112	CcSEcCtD
Sitagliptin—Hyperglycaemia—Temozolomide—malignant glioma	0.00467	0.0112	CcSEcCtD
Sitagliptin—Urinary tract infection—Carmustine—malignant glioma	0.00464	0.0111	CcSEcCtD
Sitagliptin—Pneumonia—Temozolomide—malignant glioma	0.00464	0.0111	CcSEcCtD
Sitagliptin—Infestation NOS—Temozolomide—malignant glioma	0.00461	0.011	CcSEcCtD
Sitagliptin—Infestation—Temozolomide—malignant glioma	0.00461	0.011	CcSEcCtD
Sitagliptin—Depression—Temozolomide—malignant glioma	0.0046	0.011	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00457	0.0109	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00452	0.0108	CcSEcCtD
Sitagliptin—Urinary tract infection—Temozolomide—malignant glioma	0.00448	0.0107	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Temozolomide—malignant glioma	0.00436	0.0104	CcSEcCtD
Sitagliptin—Sinusitis—Temozolomide—malignant glioma	0.00433	0.0103	CcSEcCtD
Sitagliptin—Hypoaesthesia—Carmustine—malignant glioma	0.00426	0.0102	CcSEcCtD
Sitagliptin—CYP2C8—CYP2E1 reactions—CYP2B6—malignant glioma	0.00424	0.0421	CbGpPWpGaD
Sitagliptin—Oedema peripheral—Carmustine—malignant glioma	0.00422	0.0101	CcSEcCtD
Sitagliptin—Connective tissue disorder—Carmustine—malignant glioma	0.00421	0.0101	CcSEcCtD
Sitagliptin—Hypoaesthesia—Temozolomide—malignant glioma	0.00412	0.00985	CcSEcCtD
Sitagliptin—Pharyngitis—Temozolomide—malignant glioma	0.00411	0.00983	CcSEcCtD
Sitagliptin—Urinary tract disorder—Temozolomide—malignant glioma	0.00409	0.00978	CcSEcCtD
Sitagliptin—Oedema peripheral—Temozolomide—malignant glioma	0.00408	0.00975	CcSEcCtD
Sitagliptin—Connective tissue disorder—Temozolomide—malignant glioma	0.00407	0.00973	CcSEcCtD
Sitagliptin—Urethral disorder—Temozolomide—malignant glioma	0.00406	0.00971	CcSEcCtD
Sitagliptin—Eye disorder—Carmustine—malignant glioma	0.004	0.00958	CcSEcCtD
Sitagliptin—Erythema multiforme—Temozolomide—malignant glioma	0.00391	0.00936	CcSEcCtD
Sitagliptin—Eye disorder—Temozolomide—malignant glioma	0.00387	0.00925	CcSEcCtD
Sitagliptin—Cardiac disorder—Temozolomide—malignant glioma	0.00384	0.00919	CcSEcCtD
Sitagliptin—Angiopathy—Temozolomide—malignant glioma	0.00376	0.00898	CcSEcCtD
Sitagliptin—Mental disorder—Carmustine—malignant glioma	0.00375	0.00898	CcSEcCtD
Sitagliptin—Immune system disorder—Temozolomide—malignant glioma	0.00374	0.00894	CcSEcCtD
Sitagliptin—Mediastinal disorder—Temozolomide—malignant glioma	0.00373	0.00892	CcSEcCtD
Sitagliptin—Malnutrition—Carmustine—malignant glioma	0.00373	0.00892	CcSEcCtD
Sitagliptin—Mental disorder—Temozolomide—malignant glioma	0.00363	0.00867	CcSEcCtD
Sitagliptin—Back pain—Carmustine—malignant glioma	0.00361	0.00863	CcSEcCtD
Sitagliptin—Malnutrition—Temozolomide—malignant glioma	0.0036	0.00862	CcSEcCtD
Sitagliptin—Vision blurred—Carmustine—malignant glioma	0.00351	0.00841	CcSEcCtD
Sitagliptin—Back pain—Temozolomide—malignant glioma	0.00349	0.00834	CcSEcCtD
Sitagliptin—Vision blurred—Temozolomide—malignant glioma	0.0034	0.00812	CcSEcCtD
Sitagliptin—Ill-defined disorder—Temozolomide—malignant glioma	0.00334	0.008	CcSEcCtD
Sitagliptin—Angioedema—Temozolomide—malignant glioma	0.00329	0.00788	CcSEcCtD
Sitagliptin—Malaise—Temozolomide—malignant glioma	0.00325	0.00777	CcSEcCtD
Sitagliptin—Vertigo—Temozolomide—malignant glioma	0.00324	0.00774	CcSEcCtD
Sitagliptin—Hypertension—Carmustine—malignant glioma	0.00322	0.0077	CcSEcCtD
Sitagliptin—Myalgia—Carmustine—malignant glioma	0.00317	0.00759	CcSEcCtD
Sitagliptin—Anxiety—Carmustine—malignant glioma	0.00316	0.00757	CcSEcCtD
Sitagliptin—Cough—Temozolomide—malignant glioma	0.00314	0.00752	CcSEcCtD
Sitagliptin—Hypertension—Temozolomide—malignant glioma	0.00311	0.00744	CcSEcCtD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—POR—malignant glioma	0.0031	0.0307	CbGpPWpGaD
Sitagliptin—Myalgia—Temozolomide—malignant glioma	0.00307	0.00734	CcSEcCtD
Sitagliptin—Arthralgia—Temozolomide—malignant glioma	0.00307	0.00734	CcSEcCtD
Sitagliptin—Anxiety—Temozolomide—malignant glioma	0.00306	0.00731	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00305	0.00729	CcSEcCtD
Sitagliptin—Discomfort—Temozolomide—malignant glioma	0.00303	0.00725	CcSEcCtD
Sitagliptin—Infection—Carmustine—malignant glioma	0.00302	0.00723	CcSEcCtD
Sitagliptin—Dry mouth—Temozolomide—malignant glioma	0.003	0.00718	CcSEcCtD
Sitagliptin—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.00296	0.0294	CbGpPWpGaD
Sitagliptin—Anaphylactic shock—Temozolomide—malignant glioma	0.00294	0.00703	CcSEcCtD
Sitagliptin—Infection—Temozolomide—malignant glioma	0.00292	0.00699	CcSEcCtD
Sitagliptin—Nervous system disorder—Temozolomide—malignant glioma	0.00288	0.0069	CcSEcCtD
Sitagliptin—Skin disorder—Temozolomide—malignant glioma	0.00286	0.00683	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00277	0.00663	CcSEcCtD
Sitagliptin—Insomnia—Carmustine—malignant glioma	0.00275	0.00658	CcSEcCtD
Sitagliptin—Somnolence—Carmustine—malignant glioma	0.00271	0.00647	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00268	0.00641	CcSEcCtD
Sitagliptin—Insomnia—Temozolomide—malignant glioma	0.00266	0.00636	CcSEcCtD
Sitagliptin—Decreased appetite—Carmustine—malignant glioma	0.00265	0.00633	CcSEcCtD
Sitagliptin—DPP4—Peptide hormone metabolism—BCHE—malignant glioma	0.00264	0.0262	CbGpPWpGaD
Sitagliptin—CYP2C8—Xenobiotics—CYP2B6—malignant glioma	0.00263	0.0261	CbGpPWpGaD
Sitagliptin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00263	0.00628	CcSEcCtD
Sitagliptin—Somnolence—Temozolomide—malignant glioma	0.00261	0.00625	CcSEcCtD
Sitagliptin—Pain—Carmustine—malignant glioma	0.0026	0.00622	CcSEcCtD
Sitagliptin—Constipation—Carmustine—malignant glioma	0.0026	0.00622	CcSEcCtD
Sitagliptin—Dyspepsia—Temozolomide—malignant glioma	0.00259	0.00619	CcSEcCtD
Sitagliptin—Decreased appetite—Temozolomide—malignant glioma	0.00256	0.00612	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00254	0.00607	CcSEcCtD
Sitagliptin—Fatigue—Temozolomide—malignant glioma	0.00254	0.00606	CcSEcCtD
Sitagliptin—Constipation—Temozolomide—malignant glioma	0.00252	0.00602	CcSEcCtD
Sitagliptin—Pain—Temozolomide—malignant glioma	0.00252	0.00602	CcSEcCtD
Sitagliptin—Feeling abnormal—Carmustine—malignant glioma	0.00251	0.006	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Carmustine—malignant glioma	0.00249	0.00595	CcSEcCtD
Sitagliptin—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00246	0.0244	CbGpPWpGaD
Sitagliptin—Feeling abnormal—Temozolomide—malignant glioma	0.00242	0.0058	CcSEcCtD
Sitagliptin—Abdominal pain—Carmustine—malignant glioma	0.00241	0.00575	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00241	0.00575	CcSEcCtD
Sitagliptin—Urticaria—Temozolomide—malignant glioma	0.00234	0.00559	CcSEcCtD
Sitagliptin—Abdominal pain—Temozolomide—malignant glioma	0.00233	0.00556	CcSEcCtD
Sitagliptin—CYP2C8—Xenobiotics—CYP2C18—malignant glioma	0.00228	0.0226	CbGpPWpGaD
Sitagliptin—Hypersensitivity—Carmustine—malignant glioma	0.00224	0.00536	CcSEcCtD
Sitagliptin—Asthenia—Carmustine—malignant glioma	0.00218	0.00522	CcSEcCtD
Sitagliptin—Hypersensitivity—Temozolomide—malignant glioma	0.00217	0.00518	CcSEcCtD
Sitagliptin—Asthenia—Temozolomide—malignant glioma	0.00211	0.00505	CcSEcCtD
Sitagliptin—Diarrhoea—Carmustine—malignant glioma	0.00208	0.00498	CcSEcCtD
Sitagliptin—Dizziness—Carmustine—malignant glioma	0.00201	0.00481	CcSEcCtD
Sitagliptin—Diarrhoea—Temozolomide—malignant glioma	0.00201	0.00481	CcSEcCtD
Sitagliptin—Dizziness—Temozolomide—malignant glioma	0.00194	0.00465	CcSEcCtD
Sitagliptin—Vomiting—Carmustine—malignant glioma	0.00194	0.00463	CcSEcCtD
Sitagliptin—Rash—Carmustine—malignant glioma	0.00192	0.00459	CcSEcCtD
Sitagliptin—Dermatitis—Carmustine—malignant glioma	0.00192	0.00459	CcSEcCtD
Sitagliptin—Headache—Carmustine—malignant glioma	0.00191	0.00456	CcSEcCtD
Sitagliptin—Vomiting—Temozolomide—malignant glioma	0.00187	0.00447	CcSEcCtD
Sitagliptin—Rash—Temozolomide—malignant glioma	0.00185	0.00444	CcSEcCtD
Sitagliptin—Dermatitis—Temozolomide—malignant glioma	0.00185	0.00443	CcSEcCtD
Sitagliptin—Headache—Temozolomide—malignant glioma	0.00184	0.00441	CcSEcCtD
Sitagliptin—Nausea—Carmustine—malignant glioma	0.00181	0.00432	CcSEcCtD
Sitagliptin—Nausea—Temozolomide—malignant glioma	0.00175	0.00418	CcSEcCtD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.00166	0.0165	CbGpPWpGaD
Sitagliptin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00157	0.0156	CbGpPWpGaD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.0015	0.0149	CbGpPWpGaD
Sitagliptin—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.00141	0.014	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PIM1—malignant glioma	0.0014	0.0139	CbGpPWpGaD
Sitagliptin—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.00122	0.0121	CbGpPWpGaD
Sitagliptin—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.00115	0.0114	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00109	0.0108	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00108	0.0107	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.00102	0.0101	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—XBP1—malignant glioma	0.000974	0.00967	CbGpPWpGaD
Sitagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000969	0.00962	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000946	0.0094	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—NDRG1—malignant glioma	0.000937	0.0093	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000934	0.00927	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000923	0.00916	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000885	0.00879	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—PTGS1—malignant glioma	0.00083	0.00824	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—GDNF—malignant glioma	0.000811	0.00806	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000767	0.00762	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL12A—malignant glioma	0.000742	0.00737	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—SPHK1—malignant glioma	0.000722	0.00717	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—malignant glioma	0.000698	0.00693	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000628	0.00624	CbGpPWpGaD
Sitagliptin—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000622	0.00618	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000586	0.00582	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000581	0.00577	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—TFRC—malignant glioma	0.000579	0.00575	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000578	0.00574	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—HLA-C—malignant glioma	0.000548	0.00544	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000508	0.00504	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000501	0.00498	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—BCHE—malignant glioma	0.000498	0.00495	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—FBXW7—malignant glioma	0.00049	0.00487	CbGpPWpGaD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000479	0.00476	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	0.000478	0.00475	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000475	0.00472	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP2B6—malignant glioma	0.00047	0.00467	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL12B—malignant glioma	0.000466	0.00463	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP2B6—malignant glioma	0.000464	0.0046	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000422	0.00419	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000412	0.00409	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP2C18—malignant glioma	0.000407	0.00405	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP2C18—malignant glioma	0.000402	0.00399	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000347	0.00344	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000343	0.0034	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.000332	0.00329	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTT1—malignant glioma	0.00033	0.00327	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	0.000326	0.00324	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—HLA-B—malignant glioma	0.000324	0.00322	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00032	0.00318	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000318	0.00316	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000312	0.0031	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—PTGS1—malignant glioma	0.000309	0.00307	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000303	0.00301	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—HLA-A—malignant glioma	0.0003	0.00298	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000295	0.00293	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—F2—malignant glioma	0.000283	0.00281	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00027	0.00269	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CD80—malignant glioma	0.000254	0.00252	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000252	0.0025	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000249	0.00247	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000247	0.00246	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000247	0.00245	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—MMP2—malignant glioma	0.00024	0.00238	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—RTEL1—malignant glioma	0.000231	0.00229	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTP1—malignant glioma	0.000228	0.00227	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000226	0.00224	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—GSTP1—malignant glioma	0.000225	0.00224	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000219	0.00217	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000216	0.00214	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000204	0.00203	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—RTEL1—malignant glioma	0.000201	0.002	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.0002	0.00199	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CXCL8—malignant glioma	0.000199	0.00198	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000197	0.00196	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000192	0.00191	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000192	0.00191	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000189	0.00188	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000186	0.00185	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000179	0.00178	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000179	0.00177	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000178	0.00177	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL2—malignant glioma	0.000178	0.00177	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000177	0.00176	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000177	0.00176	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000175	0.00174	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000166	0.00165	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000165	0.00164	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000161	0.0016	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00016	0.00159	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000151	0.0015	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000144	0.00143	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—COX8A—malignant glioma	0.000133	0.00132	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TNF—malignant glioma	0.00013	0.00129	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000129	0.00128	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000125	0.00124	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000124	0.00123	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000123	0.00123	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000123	0.00122	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000121	0.0012	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000119	0.00118	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—COX8A—malignant glioma	0.000116	0.00115	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ASMT—malignant glioma	0.000113	0.00112	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000111	0.00111	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00011	0.00109	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—BCAN—malignant glioma	0.000106	0.00105	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000105	0.00104	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	9.98e-05	0.000991	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	9.83e-05	0.000977	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ASMT—malignant glioma	9.83e-05	0.000976	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	9.82e-05	0.000975	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	9.8e-05	0.000973	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	9.7e-05	0.000963	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	9.48e-05	0.000941	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—BCAN—malignant glioma	9.24e-05	0.000917	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	9.02e-05	0.000896	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	8.8e-05	0.000874	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	8.59e-05	0.000853	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—IDH2—malignant glioma	8.55e-05	0.000849	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	8.27e-05	0.000821	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.06e-05	0.0008	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP2B6—malignant glioma	8.04e-05	0.000798	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	7.47e-05	0.000742	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—IDH2—malignant glioma	7.45e-05	0.000739	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—IDH1—malignant glioma	7.35e-05	0.00073	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—COX8A—malignant glioma	7.12e-05	0.000707	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SPHK1—malignant glioma	7.11e-05	0.000706	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP2B6—malignant glioma	7e-05	0.000695	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP2C18—malignant glioma	6.97e-05	0.000692	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	6.87e-05	0.000682	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	6.72e-05	0.000667	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.57e-05	0.000652	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—IDH1—malignant glioma	6.4e-05	0.000636	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	6.4e-05	0.000636	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	6.35e-05	0.00063	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SPHK1—malignant glioma	6.2e-05	0.000615	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP2C18—malignant glioma	6.07e-05	0.000603	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ASMT—malignant glioma	6.05e-05	0.000601	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.99e-05	0.000594	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	5.83e-05	0.000579	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.78e-05	0.000574	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—BCAN—malignant glioma	5.69e-05	0.000565	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	5.64e-05	0.00056	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTT1—malignant glioma	5.64e-05	0.00056	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTGS1—malignant glioma	5.28e-05	0.000524	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.26e-05	0.000522	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTT1—malignant glioma	4.91e-05	0.000488	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—BCHE—malignant glioma	4.91e-05	0.000488	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC5A5—malignant glioma	4.85e-05	0.000482	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	4.76e-05	0.000473	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTGS1—malignant glioma	4.6e-05	0.000457	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—IDH2—malignant glioma	4.59e-05	0.000456	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.59e-05	0.000455	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.54e-05	0.000451	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.31e-05	0.000428	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—BCHE—malignant glioma	4.28e-05	0.000425	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC5A5—malignant glioma	4.22e-05	0.00042	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.96e-05	0.000394	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—IDH1—malignant glioma	3.95e-05	0.000392	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTP1—malignant glioma	3.91e-05	0.000388	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.89e-05	0.000386	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SPHK1—malignant glioma	3.82e-05	0.000379	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CAT—malignant glioma	3.8e-05	0.000377	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.74e-05	0.000371	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NCOR1—malignant glioma	3.59e-05	0.000356	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTP1—malignant glioma	3.4e-05	0.000338	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CAT—malignant glioma	3.31e-05	0.000329	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NCOR1—malignant glioma	3.13e-05	0.000311	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTT1—malignant glioma	3.02e-05	0.0003	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CAV1—malignant glioma	2.93e-05	0.000291	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTGS1—malignant glioma	2.83e-05	0.000281	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.8e-05	0.000278	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CG—malignant glioma	2.67e-05	0.000265	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—BCHE—malignant glioma	2.64e-05	0.000262	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.6e-05	0.000258	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PPARG—malignant glioma	2.57e-05	0.000255	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CAV1—malignant glioma	2.55e-05	0.000253	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CD—malignant glioma	2.34e-05	0.000233	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CG—malignant glioma	2.32e-05	0.000231	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PPARG—malignant glioma	2.24e-05	0.000223	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTP1—malignant glioma	2.1e-05	0.000208	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CB—malignant glioma	2.04e-05	0.000203	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CD—malignant glioma	2.04e-05	0.000203	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CAT—malignant glioma	2.04e-05	0.000203	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTGS2—malignant glioma	2.02e-05	0.000201	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NCOR1—malignant glioma	1.93e-05	0.000191	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CB—malignant glioma	1.78e-05	0.000177	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTEN—malignant glioma	1.76e-05	0.000175	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTGS2—malignant glioma	1.76e-05	0.000175	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CAV1—malignant glioma	1.57e-05	0.000156	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTEN—malignant glioma	1.54e-05	0.000153	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.43e-05	0.000142	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PPARG—malignant glioma	1.38e-05	0.000137	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.26e-05	0.000125	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.25e-05	0.000124	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.1e-05	0.000109	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTGS2—malignant glioma	1.09e-05	0.000108	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CA—malignant glioma	1.08e-05	0.000108	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—AKT1—malignant glioma	1.02e-05	0.000101	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTEN—malignant glioma	9.47e-06	9.41e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—AKT1—malignant glioma	8.86e-06	8.8e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CA—malignant glioma	6.68e-06	6.64e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—AKT1—malignant glioma	5.46e-06	5.42e-05	CbGpPWpGaD
